Compound Detail
CHEMBL5423923
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5423923 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PLLOLRVWJKKOBK-UHFFFAOYSA-N |
| Parent Compound | CHEMBL5499406 |
| Active Moiety | CHEMBL5499406 |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
393.5
MW (Da)
2.84
ALogP
5
HBA
2
HBD
87.6
PSA (Ų)
0.84
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 7.48
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SARS-CoV-2 CHEMBL4303835 | EC50 | 7.48 | 7.48 | 33.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SARS-CoV-2 | EC50 | = | 33.0 | nM | 7.48 | Antiviral activity against SARS-CoV-2 Omicron assessed as reduction of viral gro... | 37229831 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37229831 | 10.1016/j.ejmech.2023.115503 | SARS-CoV-2 | 1 |
Data from ChEMBL 36 via Core Engine